Fortis Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Fortis Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,962	Closed	-$136K	–	109
2023 Q1	$136K	Hold	1,962	–	–	0.09%	99
2022 Q4	$141K	Hold	1,962	–	–	0.11%	94
2022 Q3	$139K	Sell	1,962 -3,350	-63%	-$243K	0.1%	104
2022 Q2	$409K	Sell	5,312 -950	-15%	-$72.4K	0.27%	52
2022 Q1	$457K	Hold	6,262	–	–	0.25%	56
2021 Q4	$390K	Buy	6,262 +3,262	+109%	+$191K	0.23%	65
2021 Q3	$178K	Buy	+3,000	New	+$198K	0.11%	96

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fortis Advisors's BMY Position: Q2 2023 in Review

Fortis Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 1,962 shares — an estimated $136K sold.

Fortis Advisors first reported a position in BMY in Q3 2021 and held it in 7 quarters. The position peaked at $457K in Q1 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Fortis Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Fortis Advisors sold 1,962 Bristol-Myers Squibb shares in Q2 2023, an estimated $136K.
Fortis Advisors first reported a position in Bristol-Myers Squibb in Q3 2021 and held it in 7 quarters.
Fortis Advisors's Bristol-Myers Squibb position peaked at $457K in Q1 2022.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Fortis Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.